PubRank

Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C

Clinical Trial ID NCT00491244

PubWeight™ 4.21‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00491244

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999 4.04
2 Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial. Ann Intern Med 2013 2.84
3 Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998 2.14
4 Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999 2.11
5 Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther 2003 1.82
6 Randomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis C. Nephrol Dial Transplant 2005 1.56
7 Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection. Nephrology (Carlton) 2007 1.55
8 Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C. J Gastroenterol Hepatol 2006 1.53
9 Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002 1.53
10 Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial. Gut 2014 1.45
11 Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000 1.21
12 Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998 1.12
13 Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients. J Viral Hepat 2006 1.06
14 Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety. Am J Gastroenterol 2003 1.02
15 Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998 1.00
16 Interferon-alpha-induced acute renal allograft rejection. Transplantation 1995 0.95
17 Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study. J Viral Hepat 2001 0.94
18 Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. Transplant Proc 2004 0.93
19 Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients. J Infect Dis 2000 0.88
20 Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis. World J Gastroenterol 2006 0.86
21 Hepatitis C virus infection and renal disease after renal transplantation. Transplant Proc 2004 0.85
22 GB virus C infection in hemodialysis patients: molecular evidence for nosocomial transmission. J Infect Dis 1999 0.83
23 Severe evolution of chronic hepatitis C in renal transplantation: a case control study. Nephrol Dial Transplant 2002 0.82
24 Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C? Clin Nephrol 2005 0.81
25 Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation. Am J Gastroenterol 2001 0.81
26 Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C. Aliment Pharmacol Ther 2004 0.81
27 Hepatitis C in renal transplantation. Kidney Int 1997 0.79
28 Intrafamilial transmission of hepatitis C virus in hemodialysis patients. J Med Virol 1995 0.77
29 Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects. Transplant Proc 1995 0.75
30 Interferon and ribavirin therapy in dialysis patients with chronic hepatitis C. Nephrol Dial Transplant 2001 0.75
Next 100